Detection of the calcium antagonist nicardipine and its metabolites by gas chromatography-mass spectrometry

Forensic Science International

Volumn 130, Issue 1, 2002, Pages 25-28

  Ikegaya, Hiroshi ^a   Kobayashi, Masahiko ^a   Sakurada, Koichi ^a   Takeichi, Hisako ^a   Yoshida, Ken ichi ^a   Iwase, Hirotaro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cerebrovascular disease; Nicardipine; Pyridine metabolite

Indexed keywords

CALCIUM ANTAGONIST; DRUG METABOLITE; NICARDIPINE; PYRIDINE;

AGED; ANALYTIC METHOD; ARTICLE; AUTOPSY; BLOOD SAMPLING; CALIBRATION; CAPILLARY GAS CHROMATOGRAPHY; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG OVERDOSE; HUMAN; MALE; MALPRACTICE; MASS SPECTROMETER; MASS SPECTROMETRY; PARKINSON DISEASE; PRIORITY JOURNAL; SUDDEN DEATH;

EID: 0037027481     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0379-0738(02)00300-6     Document Type: Article

References (12)

1. Iwanami M., Higuchi S., Takanaka T., Ichimura T., Sado T. Synthesis of new water-soluble dihydropyridine vasodilators. Chem. Pharm. Bull. 27(6):1979;1426.
2. Sorkin E.M., Clissold S.P. Nicardipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders. Drug. 33:1987;296.
3. A.P. Somlyo, Ultrastructure and function of vascular smooth muscle, in: S. Wolf, N.T. Wetheseen (Eds.), The Smoothe Muscle of the Artery, Plenum Press, New York, 1980, pp.1-80.
4. Satoh K.et al. Calcium-channel blockade in the cardiovascular action of a new dihydropyridine vasodilator, YC-93. Clin. Exp. Pharmacol. Physiol. 7:1980;249-262.
5. Iwaoka T.et al. Determination of (+)- and (-)-nicardipine concentrations in human serum and their correlation with the antihypersensitive effect after oral administration of racemic nicardipine. Eur. J. Clin. Pharmacol. 48:1995;345-349.
6. Higuchi S., Shrobara Y. Comparative pharmacokinetics of nicardipine hydrochloride, a new vaso dilator in various species. Xenobiotica. 10:1980;447.
7. Hirota Y.et al. A clinical evaluation of the intravenous nicardipine therapy for acute heart failure. Jpn. Pharmacol. Ther. 23(3):1995;164-173.
8. M. Kinoshita, et al., Acute effects of a single dose of intravenous administration of nicardipine hydrochloride in patients with acute heart failure: Early phase II study, Jpn. Pharmacol. Ther. 23 (2) 133-142.
9. Moorkherjee S.et al. Hemodynamic, ventilatory and blood gas changes during infusion of sodium nitroferriccyanide (nitroprusside): studies in patients with congestive heart failure. Chest. 72(3):1977;273.
10. Renard M.et al. Pimobendane (UD-CG115BS) in chronic congestive heart failure. Chest. 93(6):1988;1159-1164.
11. Pierpont G.et al. Effects of vasodilators on pulmonary hemodynamics and gas exchange in left ventricular failure. Am. Heart J. 99:1980;208.
12. Odani Y., Sado T. Acute toxicity study of nicardipine hydrochloride (YC-93) in rats and mice. Oyouyakuri. 18(2):1979;301-307.